Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Neurovascular Thrombectomy Devices Market Report Overview

The Neurovascular Thrombectomy Devices market size was $872.5 million in 2023. Factors such as constant revision of protocol and best practice guidelines will drive the market growth at a CAGR of more than 8% from 2023 to 2033.

Neurovascular Thrombectomy Devices are used to remove blood clots in the neurovascular vessels during an acute ischemic stroke. In general, the incidence rate of ischemic strokes is likely to increase over the forecast period due to population growth, high aging population, and improvements in diagnostic techniques and facilities.

Neurovascular Thrombectomy Devices Market Outlook, 2023-2033 ($ Million)

Neurovascular Thrombectomy Devices Market Outlook, 2023-2033 ($ Million)

Buy the Full Report for More Insights into the Neurovascular Thrombectomy Devices Market Forecast
Download A Free Report Sample

The neurovascular thrombectomy devices market research report identifies quantitative market trends within drug delivery devices therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the neurovascular thrombectomy devices market for 2020 and beyond. Furthermore, the report provides neurovascular thrombectomy devices market share by company that will help in identifying untapped market opportunities.

Market Size (2023) $872.5 million
CAGR (2023-2033) >8%
Forecast Period 2023-2033
Historical Period 2015-2023
Key Segments ·        Aspiration Catheters

·        Stent Retrievers

Key Regions ·        North America

·        Europe

·        Asia Pacific

·        South Central America

·        Middle East and Africa

Leading Companies ·        Medtronic Plc

·        Stryker Corp

·        Cerenovus

·        Penumbra Inc

·        MicroVention Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Neurovascular Thrombectomy Devices Market Segments

The key segments of the neurovascular thrombectomy devices market are Aspiration Catheters and Stent Retrievers. Stent Retrievers led the neurovascular thrombectomy devices market in 2023. They are deployed by a catheter that is threaded through the clot. Once the stent is fully deployed, the stent is retrieved with the clot attached. One unit refers to one stent retriever.

An aspiration catheter is a micro-vacuum that is fed into affected vessels to remove large vessel occlusions during an acute ischemic stroke. One unit refers to one aspiration catheter.

Neurovascular Thrombectomy Devices Market Analysis by Segments, 2023 (%)

Neurovascular Thrombectomy Devices Market Analysis by Segments, 2023 (%)

Buy Full Report for More Insights into the Neurovascular Thrombectomy Devices Market Segment

Download A Free Report Sample

Regional Analysis of Neurovascular Thrombectomy Devices Market

The key regions in the Neurovascular Thrombectomy Devices market are North America, Europe, Asia-Pacific, South Central America, and the Middle East and Africa. North America dominated the market in 2023.

The number of thrombectomy procedures in North America will grow during the forecast period. It is evident that thrombectomy procedures, in combination with t-PA, are extremely effective in treating acute ischemic strokes. Additionally, the procedures using aspiration catheter devices will experience a higher growth rate since these are quicker compared to stent retriever procedures.

Neurovascular Thrombectomy Devices Market Analysis by Regions, 2023 (%)

Neurovascular Thrombectomy Devices Market Analysis by Regions, 2023 (%)

Buy the Full Report to Know More about the Regions in the Neurovascular Thrombectomy Devices Market

Download A Free Report Sample

Neurovascular Thrombectomy Devices Market - Competitive Landscape

In 2023, Medtronic’s neurovascular thrombectomy devices market share was the highest

The major players in the neurovascular thrombectomy devices market are:

  • Medtronic Plc
  • Stryker Corp
  • Cerenovus
  • Penumbra Inc
  • MicroVention Inc

The key strategies that major companies follow are entering the market with new and innovative devices, they make great acquisition targets. Generally, a broad portfolio of products is a way to develop expertise within the space and a solid position in the market. Companies with a broad portfolio will benefit from this.

Companies that were previously limited to the stent retrievers market have also expanded their portfolio into the aspiration catheter device market.

Neurovascular Thrombectomy Devices Market Analysis by Companies, 2023 (%)

Neurovascular Thrombectomy Devices Market Analysis by Companies, 2023 (%)

Buy the Full Report for more Company-Wise Insights into the Neurovascular Thrombectomy Devices Market

Download A Free Report Sample

Neurovascular Thrombectomy Devices Market Dynamics

Drivers: The key factors positively impacting the neurovascular thrombectomy devices market were constant revision of protocol and best practice guidelines to ensure patients can receive timely treatment. Also, reimbursement of devices will support the market growth.

Barriers: Factors such as the Lack of trained specialists available 24 hours to perform neurovascular thrombectomy procedures may affect the demand for the neurovascular thrombectomy devices market. Also, an insufficient number of INR facilities will negatively impact neurovascular thrombectomy devices market growth.

Future Outlook: Factors that may limit growth, advancements in protocol, technology, and logistics are constantly being revisited in each country. This will help to overcome the challenges and provide better care for stroke patients.

Segments Covered in the Report

Neurovascular Thrombectomy Devices Segments Outlook (Value, $ Million, 2015-2033)

  • Aspiration Catheters
  • Stent Retrievers

Neurovascular Thrombectomy Devices Regional Outlook (Value, $ Million, 2015-2033)

  • North America
  • Europe
  • Asia Pacific
  • South Central America
  • Middle East and Africa

Key Inclusions

  • The neurovascular thrombectomy devices market research report includes an insightful review of the key industry trends.
  • The neurovascular thrombectomy devices market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
  • The report also includes market-level data on units, average selling prices, and market values.

Regional, Country, and Global Infusion Pumps Market Insights:

  • The neurovascular thrombectomy devices market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • The neurovascular thrombectomy devices market SWOT analysis.
  • The report provides trends and Infusion Pumps market competitive dynamics.

Buy the Full Report for More Insights on the neurovascular thrombectomy devices market share, Download a Free Sample Report

Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. Also, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.

Companies covered – Cerenovus, Medtronic Plc, Phenox GmbH, MicroVention Inc, Stryker Corp, Imperative Care Inc, Rapid Medical, Penumbra Inc, Balt SAS, Acandis GmbH & Co KG and Others.

Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

  • Extensive coverage of the infusion pump market under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of the neurovascular thrombectomy devices market and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Understand the COVID-19 impact on the neurovascular thrombectomy devices market.
  • Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving neurovascular thrombectomy devices.
  • Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
  • Formulate effective sales and marketing strategies with a detailed evaluation of neurovascular thrombectomy devices market share by company. Identify strong competitors and create winning strategies to stand out in the global neurovascular thrombectomy devices market.
  • Track regional neurovascular thrombectomy devices market sales as well as country-specific transactions from 2015-2033.
  • Organize your sales and marketing efforts by identifying the global neurovascular thrombectomy devices market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.

Cerenovus
Medtronic Plc
Phenox GmbH
MicroVention Inc
Stryker Corp
Imperative Care Inc
Rapid Medical
Penumbra Inc
Balt SAS
Acandis GmbH & Co KG
Others

Frequently asked questions

Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 thematic reports
Currency USD
$7,500

Can be used by individual purchaser only

$22,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 in real time.

  • Access a live Neurovascular Thrombectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.